Strides Pharma Science Board Meeting on July 31, 2026

Strides Pharma Science Ltd has announced that its Board of Directors will convene on July 31, 2026. The primary agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2026, on both standalone and consolidated bases. Additionally, the company will address other business matters. In line with the company's insider trading policy, the trading window for designated persons will remain closed from July 1, 2026, until 48 hours after the financial results are declared. The company's website will also host this information.